– Akums Drugs and Pharmaceuticals IPO closed its subscription to investors on August 01
– Akums Drugs is a pharmaceutical contract development and manufacturing organisation
– IPO price band was kept in a range of Rs 646 to Rs 679 per equity share
– Listing of stock is expected to take place on NSE and BSE on August 06
– Raised Rs 1,856.74 crores from investors through fresh shares and offer for sale
– Employees were offered 243,902 shares at a discounted price of Rs 64 per equity share
– Analysts recommend subscribing to the IPO for long-term perspective
– Youngsters are advised to prioritize safety, diversify, understand investments, maintain discipline and long-term perspective in financial planning.